Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN

Overview of attention for article published in New England Journal of Medicine, December 2025

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

news: 25 news outlets
blogs: 2 blogs
twitter: 143 X users
facebook: 1 Facebook page

reddit: 1 Redditor
bluesky: 27 Bluesky users
podcasts: 2 podcasts

Readers on

mendeley: 58 Mendeley

So far, Altmetric has seen 171 X posts from 143 X users, with an upper bound of 1,421,738 followers.

Źródło: New England Journal of Medicine (VALIANT), grudzień 2025. https://t.co/8korVLhB0c

Źródło: New England Journal of Medicine, grudzień 2025. https://t.co/8korVLhB0c

RT @NEJM: Original Article: Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN (VALIANT phase 3 trial) https://t.co/YcOMok…

RT @NephJC: 1/10 Last #NephJC we discussed pegcetacoplan in C3 glomerulopathy and Immune-Complex MPGN #TenPostNephJC Given the central ro…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 167 additional X posts.